Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
06/2003
06/05/2003CA2466870A1 Methods for treating autoimmune disorders, and reagents related thereto
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/04/2003EP1316561A1 Fusion protein having enhanced in vivo erythropoietin activity
06/04/2003EP1316319A1 A novel gene therapy agent for haemophilia b and its preparation method
06/04/2003EP1316313A2 Composition for the treatment of ischemic stroke containing zonampanel and a tissue plasminogen activator
06/04/2003EP1316312A1 Use of the Hibiscus sabdariffa extract in the preparation of a medicament
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315835A2 Directed differentiation of embryonic cells
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315804A2 Novel mmp-2 derivatives for use as inhibitors of integrin alpha vbeta 3
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315756A2 Electroprocessed fibrin-based matrices and tissues
06/04/2003EP1315735A1 Phosphate derivatives as immunoregulatory agents
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315708A1 Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
06/04/2003EP1315704A1 2-guanidino-4-aryl-quinazoline
06/04/2003EP1315539A2 Antithrombotic compositions
06/04/2003EP1315513A2 "pseudo"-native chemical ligation
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315511A2 Synthetic erythropoiesis stimulating proteins
06/04/2003EP1315480A2 "slow release" pharmaceutical compositions comprising lithium carbonate
06/04/2003EP1232156B1 [1,2,3]-TRIAZOLO[4,5-d]PYRIMIDINE DERIVATIVES AS ANTI-THROMBOTIC AGENTS
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP0944616B1 Bicyclic aryl carboxamides and their therapeutic use
06/04/2003EP0571602B1 Dimer of molecular variant of apolipoprotein and processes for the production thereof
06/04/2003CN1422283A Glycosaminoglycans derived from the K5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation
06/04/2003CN1422273A 1,5-disubstituted-3,4-dihydro-1H-pyrimido [4,5-D] pyrimidi-2-one compounds and their use in treating CSBP/P38 kinase mediated diseases
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422260A 2-guanidino-4-arylchinazolines as NHE-3 inhibitors
06/04/2003CN1421461A Fusion protein with reinforced erythrocytin activity in vivo
06/04/2003CN1421245A Recombinant human interleukin-11 prepn for injection and its prepn process
06/04/2003CN1421244A Application of osteogenic growth peptide in promoting bematogenesis
06/04/2003CN1421231A Chinese medicine fast-acting ointment for treating septicemia
06/04/2003CN1421207A Control released osmotic pump prepn containing ligustrazine phosphate and its prepn process
06/04/2003CN1110320C Medicine preparation containing glucokinase and its preparation method
06/04/2003CN1110318C Antithrombosis medicine using inactive insuline as skeleton and containing arginine-glycine-aspartic acid sequence
06/04/2003CN1110305C Naphthyl-substituted benzimidazole derivatives as anticoagulants
06/03/2003US6573364 Isolation and characterization of Hermansky Pudlak Syndrome (HPS) protein complexes and HPS protein-interacting proteins
06/03/2003US6573264 Heteroaryl alkyl piperazine derivatives
06/03/2003US6573259 Inhibitors of interleukin-1β converting enzyme
06/03/2003US6573071 Given amino acid sequence with a modification resulting in a different processing site; use in treating blood disorders
06/03/2003CA2413491A1 Treatment for ischemic stroke
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
06/03/2003CA2115432C Substituted .beta.-amino acid derivatives useful as platelet aggregation inhibitors
05/2003
05/30/2003WO2003044021A2 Substituted indolizine-like compounds and methods of use
05/30/2003WO2003044014A1 Indole-2-carboxamides as factor xa inhibitors
05/30/2003WO2003044010A1 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
05/30/2003WO2003043988A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient
05/30/2003WO2003043981A1 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
05/30/2003WO2003043651A1 Drug mobilizing pluripotent stem cells from tissue into peripheral blood
05/30/2003WO2003043418A1 Anti-pathogenic composition useful in blood preservation
05/30/2003WO2003013442A3 Catechins for the treatment of fibrillogenesis in alzheimer's disease, parkinson's disease, systemic aa amyloidosis, and other amyloid disorders
05/30/2003WO2002100898A3 Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and dna coding for the same
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002089675A3 Wound closure system and methods
05/30/2003WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003CA2467856A1 Anti-pathogenic composition useful in blood preservation
05/30/2003CA2467752A1 Piperidin-2-one derivative compounds and pharmaceutical composition comprising the same as active ingredient
05/30/2003CA2467557A1 Agent which mobilizes multipotential stem cells from tissues to peripheral blood
05/30/2003CA2466072A1 Substituted indolizine-like compounds and methods of use
05/29/2003US20030100608 1,4-disubstituted benzo-fused cycloalkyl urea compounds
05/29/2003US20030100594 Carbonic anhydrase inhibitor
05/29/2003US20030100570 Immunomodulation and effect on cell processes relating to serotonin family receptors
05/29/2003US20030100563 Such as 7-((3R)-3-amino-4-(3,4-difluorophenyl)butanoyl)-2-(trifluoromethyl)-5,6,7,8 -tetrahydroimidazo(1,2-a)pyrazine dihydrochloride for treatment of insulin resistance disorders
05/29/2003US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy
05/29/2003US20030100510 Crystallized structure of type IV collagen NC1 domain hexamer
05/29/2003US20030100487 Glycosaminoglycan-antithrombin III/heparin cofactor II conjugates
05/29/2003US20030100014 Apolipoprotein biopolymer markers predictive of type II diabetes
05/29/2003US20030099978 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
05/29/2003US20030099765 Process for coating a surface of a stent
05/29/2003US20030099747 Thickened oil compositions of edible oil
05/29/2003US20030099694 Method for the improvement of transport across adaptable semi-permeable barriers
05/29/2003US20030099661 Compositions and methods for the treatment of immune related diseases
05/29/2003US20030099654 Comprises antibodies/proteins providing inhibition of prothrombinase; treatment and prevention of bacterial and viral infections, allograft/xenograft rejection, glomerulo-nephritis, cancer, gastrointestinal diseases, and fetal loss
05/29/2003US20030099618 Administering a genetic engineered virus virions, comprising a nucleotide sequence able to code antihemophilic factor protein; patient's blood will able to clot
05/28/2003EP1314733A1 Indole-2-carboxamides as factor Xa inhibitors
05/28/2003EP1313733A1 Pyrazolopyridine compound and pharmaceutical use thereof
05/28/2003EP1313716A1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists
05/28/2003EP1313496A1 Use of a composition comprising an extract of pollen for the treatment of edema
05/28/2003EP1313495A1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
05/28/2003EP1313494A1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
05/28/2003EP1313493A1 Use of a composition comprising an extract of pollen for the treatment of irritability
05/28/2003EP1313492A1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
05/28/2003EP1313461A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
05/28/2003EP1313453A1 Particulate vectors for improving oral absorption of active principles
05/28/2003EP1313450A1 A method of treating a systemic disease
05/28/2003EP1165115B1 Modulation of vascular permeability by mean of tie2 receptor activators
05/28/2003EP1146885B1 Pre-conditioning against cell death
05/28/2003EP1140035B1 Method for preparing an effervescent granulate comprising iron gluconate, granulate thus obtained and tablets containing the same
05/28/2003EP1049706B1 New pentasaccharides, their methods of production and pharmaceutical compositions containing same
05/28/2003EP0928294B1 Method and apparatus for preparing an acellular red blood cell substitute
05/28/2003EP0871457B1 Isolated stromal cells and methods of using the same
05/28/2003EP0788509B1 Therapeutic peptide derivatives
05/28/2003EP0748215B1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use
05/28/2003CN1420933A Method of inducing angiogenesis by micro-organs
05/28/2003CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them
1 ... 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 ... 671